Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors

Cancer Cell

Volumn 4, Issue 4, 2003, Pages 291-299

  Sikder, Hashmat ^a   Huso, David L ^b   Zhang, Hong ^c   Wang, Binghe ^b   Ryu, Byungwoo ^a   Hwang, Sam T ^c   Powell, Jonathan D ^a   Alani, Rhoda M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; GENE PRODUCT; INHIBITOR OF DIFFERENTIATION 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN TUMOR; T LYMPHOCYTE; TUMOR CELL; TUMOR GROWTH; TUMOR MODEL; TUMOR XENOGRAFT; WILD TYPE;

ANIMALIA;

EID: 0142258071     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00245-9     Document Type: Article

References (31)

1. Bain G., Romanow W.J., Albers K., Havran W.L., Murre C. Positive and negative regulation of V(D)J recombination by the E2A proteins. J. Exp. Med. 189:1999;289-300.
2. Baird A.M., Gerstein R.M., Berg L.J. The role of cytokine receptor signaling in lymphocyte development. Curr. Opin. Immunol. 11:1999;157-166.
3. Becker-Herman S., Lantner F., Shachar I. Id2 negatively regulates B cell differentiation in the spleen. J. Immunol. 168:2002;5507-5513.
4. Benezra R., Rafii S., Lyden D. The Id proteins and angiogenesis. Oncogene. 20:2001;8334-8341.
5. Bergers G., Javaherian K., Lo K.M., Folkman J., Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 284:1999;808-812.
6. Folkman J. Tumor angiogenesis. therapeutic implications N. Engl. J. Med. 285:1971;1182-1186.
7. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29:2002;15-18.
8. Girardi M., Oppenheim D.E., Steele C.R., Lewis J.M., Glusac E., Filler R., Hobby P., Sutton B., Tigelaar R.E., Hayday A.C. Regulation of cutaneous malignancy by gammadelta T cells. Science. 294:2001;605-609.
9. Hacker C., Kirsch R.D., Ju X.S., Hieronymus T., Gust T.C., Kuhl C., Jorgas T., Kurz S.M., Rose-John S., Yokota Y., Zenke M. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4:2003;380-386.
10. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
11. Herbst R.S., Hess K.R., Tran H.T., Tseng J.E., Mullani N.A., Charnsangavej C., Madden T., Davis D.W., McConkey D.J., O'Reilly M.S.et al. Phase I study of recombinant human endostatin in patients with advanced solid tumors. J. Clin. Oncol. 20:2002;3792-3803.
12. Hwang S.T. Mechanisms of T-cell homing to skin. Adv. Dermatol. 17:2001;211-241.
13. Kerbel R., Folkman J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer. 2:2002;727-739.
14. Langlands K., Down G.A., Kealey T. Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. Cancer Res. 60:2000;5929-5933.
15. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L.et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7:2001;1194-1201.
16. Lyden D., Young A.Z., Zagzag D., Yan W., Gerald W., O'Reilly R., Bader B.L., Hynes R.O., Zhuang Y., Manova K., Benezra R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 401:1999;670-677.
17. Morrow M.A., Mayer E.W., Perez C.A., Adlam M., Siu G. Overexpression of the Helix-Loop-Helix protein Id2 blocks T cell development at multiple stages. Mol. Immunol. 36:1999;491-503.
18. Mortier L., Marchetti P., Delaporte E., Martin de Lassalle E., Thomas P., Piette F., Formstecher P., Polakowska R., Danze P.M. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor. Cancer Lett. 176:2002;205-214.
19. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N.et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:2001;50-56.
20. Murakami T., Maki W., Cardones A.R., Fang H., Tun Kyi A., Nestle F.O., Hwang S.T. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 62:2002;7328-7334.
21. Rivera R.R., Johns C.P., Quan J., Johnson R.S., Murre C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity. 12:2000;17-26.
22. Salcedo R., Oppenheim J.J. Role of chemokines in angiogenesis. CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses Microcirculation. 10:2003;359-370.
23. Slaga T.J., Budunova I.V., Gimenez-Conti I.B., Aldaz C.M. The mouse skin carcinogenesis model. J. Investig. Dermatol. Symp. Proc. 1:1996;151-156.
24. Staller P., Sulitkova J., Lisztwan J., Moch H., Oakeley E.J., Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature. 425:2003;307-311.
25. Sun X.H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell. 79:1994;893-900.
26. Tachibana K., Hirota S., Iizasa H., Yoshida H., Kawabata K., Kataoka Y., Kitamura Y., Matsushima K., Yoshida N., Nishikawa S.et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature. 393:1998;591-594.
27. Volpert O.V., Pili R., Sikder H.A., Nelius T., Zaichuk T., Morris C., Shiflett C.B., Devlin M.K., Conant K., Alani R.M. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell. 2:2002;473-483.
28. Wiley H.E., Gonzalez E.B., Maki W., Wu M.T., Hwang S.T. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J. Natl. Cancer Inst. 93:2001;1638-1643.
29. Yan W., Young A.Z., Soares V.C., Kelley R., Benezra R., Zhuang Y. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17:1997;7317-7327.
30. Yokota Y., Mansouri A., Mori S., Sugawara S., Adachi S., Nishikawa S., Gruss P. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 397:1999;702-706.
31. Yuspa S.H., Dlugosz A.A., Denning M.F., Glick A.B. Multistage carcinogenesis in the skin. J. Investig. Dermatol. Symp. Proc. 1:1996;147-150.